Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary

1999/01/01 by Joseph W. Chow, Victor L. Yu · 30 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Bacterial Identification and Susceptibility Testing #Antibiotics Pharmacokinetics and Efficacy #Antibiotic Resistance in Bacteria

paper · doi:10.1016/s0924-8579(98)00060-0

Cited by

• Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
• An interdisciplinary infectious disease support team with longitudinal process interventions is associated with lower 28-day mortality in bacteremia: a single-center cohort study
• Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
• A prospective, multicenter case control study of risk factors for acquisition and mortality in Enterobacter species bacteremia
• Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae
• Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. [europepmc]
• Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. [europepmc]
• Outpatient prescription practices in rural township health centers in Sichuan Province, China. [europepmc]
• Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. [europepmc]
• Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. [europepmc]
• β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone. [europepmc]
• Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control study. [europepmc]
• Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. [europepmc]
• Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. [europepmc]
• Nanomedicine in the Management of Microbial Infection - Overview and Perspectives. [europepmc]
• External validation of bloodstream infection mortality risk score in a population-based cohort. [europepmc]
• Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study. [europepmc]
• Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates. [europepmc]
• Multidrug evolutionary strategies to reverse antibiotic resistance. [europepmc]
• Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. [europepmc]
• Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries. [europepmc]
• Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States. [europepmc]
• Robust, linear correlations between growth rates and β-lactam-mediated lysis rates. [europepmc]
• Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. [europepmc]
• Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital. [europepmc]
• The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections. [europepmc]
• Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features. [europepmc]
• Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. [europepmc]
• Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series. [europepmc]
• Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial. [europepmc]